RecruitingNot ApplicableNCT05455307

Efficacy and Safety of Allium Ureteral Stent for Treating Refractory Ureteral Stricture

Efficacy and Safety of Self-expanding Ureteral Stent for Treating Refractory Ureteral Stricture: Results of a Multicenter Experience

Sponsor

En Chu Kong Hospital

Enrollment

200 participants

Start Date

Jul 30, 2022

Study Type

INTERVENTIONAL

Conditions

Ureteral Stenosis Hydronephrosis Ureteral Stent Occlusion

Summary

To conduct a prospective, multi-center study to observe the long-term efficacy and safety of self expanding ureteral stent for treating participants with refractory ureteral stricture.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Allium ureteral stent for people with hydronephrosis, ureteral stenosis, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.